This inventor holds 5 USPTO granted patents. Top assignees: Mitsui Toatsu Chemicals, Incorporated, Mitsui Chemicals, Inc.. Active years: 1992-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mobara, JP (1992)
- Yokohama, JP (1992 - 1993)
- Tokyo, JP (1998 - 2000)
Company Filing History:

Years Active: 1992-2000
Title: Nobumi Kusuhara: Innovator in Human Growth Hormone Research
Introduction
Nobumi Kusuhara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of human growth hormone preparations. With a total of 5 patents to his name, Kusuhara's work has had a considerable impact on medical science.
Latest Patents
Kusuhara's latest patents include a pharmaceutical preparation containing human growth hormone. This stable formulation involves the addition of a water-soluble heterocyclic compound, such as creatinine, to prevent the insolubilization of the hormone in aqueous solutions. Another significant patent is the purification process of human growth hormone, which utilizes a blue pigment-bonded carrier to selectively adsorb the hormone. This method allows for the mass production of a highly purified human growth hormone, enhancing its availability for therapeutic use.
Career Highlights
Throughout his career, Nobumi Kusuhara has worked with prominent companies such as Mitsui Toatsu Chemicals, Incorporated and Mitsui Chemicals, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Kusuhara has collaborated with notable colleagues, including Hideki Kobayashi and Maki Suzuki. Their combined efforts have further advanced research in the field of human growth hormone.
Conclusion
Nobumi Kusuhara's contributions to pharmaceutical research, particularly in human growth hormone, highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile